SEC 13F Intelligence

Managers / Q2 2022 · view latest →

Amitell Capital Pte Ltd

CIK 0001807559 · 76B AMOY STREET, SINGAPORE, U0, 069895 · (65) 69093870

Reported Value
$44M
Q2 2022
Positions
19
Filings on Record
22
2021–present window
Filed
Aug 12, 2022
original filing

Summary

Amitell Capital Pte Ltd reported $44M in U.S.-listed holdings across 19 positions for Q2 2022.

Its largest position, Health Sciences Acq Corp 2, represents 13.6% of the portfolio.

Compared with Q1 2022, the fund opened 6 new positions and exited 49.

Portfolio Metrics

Turnover
+21.1%
vs prior filed quarter
Top-10 Concentration
+78.2%
share of reported value
Largest Position
+13.6%
Health Sciences Acq Corp 2
New / Exited
6 / 49
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’20: $164MQ4 ’20Q1 ’21: $159MQ2 ’21: $162MQ3 ’21: $154MQ3 ’21Q4 ’21: $144MQ1 ’22: $172MQ2 ’22: $44MQ2 ’22Q3 ’22: $50MQ4 ’22: $105MQ1 ’23: $97MQ1 ’23Q2 ’23: $203MQ3 ’23: $187MQ4 ’23: $125MQ4 ’23Q1 ’24: $118MQ2 ’24: $120MQ3 ’24: $137MQ3 ’24Q4 ’24: $123MQ1 ’25: $144MQ2 ’25: $193MQ2 ’25Q3 ’25: $164MQ4 ’25: $89MQ1 ’26: $62MQ1 ’26filingsflow.com

Portfolio Composition

By security type
Common Stock: 61.1%Other: 28.1%ETP: 10.5%Closed-End Fund: 0.2%REIT: 0.0%
  • Common Stock · 61.1% · $27M
  • Other · 28.1% · $12M
  • ETP · 10.5% · $5M
  • Closed-End Fund · 0.2% · $90,000
  • REIT · 0.0% · $5,000

Quarter-over-Quarter Changes full breakdown →

vs Q1 2022 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
SPDR GOLD TRNEW+33.0K33.0K+$6M$6M
XLESELECT SECTOR SPDR TRNEW+64.7K64.7K+$5M$5M
FISFIDELITY NATL INFORMATION SVNEW+36.8K36.8K+$3M$3M
THCTENET HEALTHCARE CORPNEW+42.8K42.8K+$2M$2M
EZPWEZCORP INCNEW+111.6K111.6K+$838,000$838,000
ALTISOURCE PORTFOLIO SOLNS SNEW+75.5K75.5K+$811,000$811,000
BERRY GLOBAL GROUP INCADDED+53.6K54.2K+$3M$3M
FCNCAFIRST CTZNS BANCSHARES INC NADDED+1.5K1.6K+$999,000$1M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2022

18 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1HEALTH SCIENCES ACQ CORP 2ORD SHS13.61%$6M600.1K
2XLESELECT SECTOR SPDR TRhistory →ENERGY10.54%$5M64.7K
3TAUSDTRAVELCENTERS OF AMERICA INChistory →COM NEW9.70%$4M123.7K
4SPROTT PHYSICAL GOLD TRUNIT9.59%$4M297.1K
5FISFIDELITY NATL INFORMATION SVhistory →COM7.68%$3M36.8K
6BERRY GLOBAL GROUP INCCOM6.74%$3M54.2K
7APOAPOLLO GLOBAL MGMT INChistory →COM6.66%$3M60.3K
8INSWINTERNATIONAL SEAWAYS INChistory →COM5.48%$2M113.6K
9THCTENET HEALTHCARE CORPhistory →COM NEW5.12%$2M42.8K
10RCKTROCKET PHARMACEUTICALS INChistory →COM3.05%$1M97.3K
11FCNCAFIRST CTZNS BANCSHARES INC Nhistory →CL A2.34%$1M1.6K
12STOKSTOKE THERAPEUTICS INChistory →COM1.95%$856,00064.8K
13EZPWEZCORP INChistory →CL A NON VTG1.91%$838,000111.6K
14ALTISOURCE PORTFOLIO SOLNS SREG SHS1.85%$811,00075.5K
15PTGXPROTAGONIST THERAPEUTICS INCCOM0.90%$397,00050.1K
16NBBNUVEEN TAXABLE MUNICPAL INMCOM0.20%$90,0005.0K
17GBDCGOLUB CAP BDC INCCOM0.02%$9,000672
18BXMTBLACKSTONE MTG TR INCCOM CL A0.01%$5,000185

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$62M14May 11, 202613F-HRchanges · EDGAR ↗
Q4 2025$89M20Feb 12, 202613F-HRchanges · EDGAR ↗
Q3 2025$164M44Nov 12, 202513F-HRchanges · EDGAR ↗
Q2 2025$193M51Aug 12, 202513F-HRchanges · EDGAR ↗
Q1 2025$144M49May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$123M38Feb 13, 202513F-HRchanges · EDGAR ↗
Q3 2024$137M40Nov 13, 202413F-HRchanges · EDGAR ↗
Q2 2024$120M40Aug 13, 202413F-HRchanges · EDGAR ↗
Q1 2024$118M40May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$125M35Feb 9, 202413F-HRchanges · EDGAR ↗
Q3 2023$187M35Nov 13, 202313F-HRchanges · EDGAR ↗
Q2 2023$203M38Aug 10, 202313F-HRchanges · EDGAR ↗
Q1 2023$97M30May 12, 202313F-HRchanges · EDGAR ↗
Q4 2022$105M35Feb 7, 202313F-HRchanges · EDGAR ↗
Q3 2022$50M23Nov 10, 202213F-HRchanges · EDGAR ↗
Q2 2022$44M19Aug 12, 202213F-HRchanges · EDGAR ↗
Q1 2022$172M62May 13, 202213F-HRchanges · EDGAR ↗
Q4 2021$144M49Feb 8, 202213F-HRchanges · EDGAR ↗
Q3 2021$154M50Nov 8, 202113F-HRchanges · EDGAR ↗
Q2 2021$162M45Aug 13, 202113F-HRchanges · EDGAR ↗
Q1 2021$159M48May 14, 202113F-HRchanges · EDGAR ↗
Q4 2020$164M51Feb 16, 202113F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.